Hugh Sweeney

Skip to main content All experts

DIRECTOR & EMINENT SCHOLAR

MD-PHARMACOLOGY - THERAPEUTICS

Orcid identifier0000-0002-6290-8853 (opens in a new tab)⁠

DIRECTOR & EMINENT SCHOLAR
MD-PHARMACOLOGY - THERAPEUTICS

lsweeney@ufl.edu (opens in a new tab)

sort by:

GRANT
Potential therapies for the muscular dystrophies
Parent Project Muscular Dystrophy18 Jul 2025 - 31 Jul 2030
Active
GRANT
Addressing Shortcomings of AAV GeneTherapies for the Muscular Dystrophies
National Institute of Health Nichd31 Mar 2025 - 31 Jul 2030
Active
GRANT
A Stealth approach to preventing mitochondrial uncoupling to slow the progression of DMD
Stealth Biotherapeutics Inc21 Sep 2023 - 20 Sep 2025
Expired
GRANT
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
National Institute of Health Niams15 Sep 2023 - 31 Aug 2027
Active
GRANT
Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma
National Institute of Health Ninds20 Jun 2023 - 31 Mar 2025
Expired
GRANT
Optimizing the design of micro-dystrophin-PTC Therapeutics GT Research Agreement
Ptc Therapeutics23 Aug 2022 - 13 Aug 2023
Expired
GRANT
Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma
National Institute of Health Ninds7 Jun 2022 - 31 Mar 2023
Expired
GRANT
Preclinical work to enable clinical trials with AAV delivery of genes to prevent heart failure
Sarepta Therapeutics24 Mar 2022 - 26 Sep 2024
Expired
GRANT
Support for 2022 New Directions in Biology and Disease of Skeletal Muscle Conference
Muscular Dystrophy Association21 Mar 2022 - 14 Aug 2022
Expired
GRANT
Drug Discovery for First-in-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma
National Institute of Health Ninds17 Mar 2022 - 1 Apr 2022
Expired
GRANT
Validation of NOX4 as a potential target to re-balance repair/replacement in BMD and identification of responsive therapeutic biomarkers
Fulcrum Therapeutics Inc3 Feb 2022 - 31 Jul 2023
Expired
GRANT
Preclinical work to enable clinical trials with AAV delivery of genes to prevent heart failure#
Sarepta Therapeutics18 Oct 2021 - 31 Dec 2021
Expired
GRANT
Potential therapies for the muscular dystrophies
Parent Project Muscular Dystrophy1 Aug 2021 - 31 Jul 2025
Expired
GRANT
Understanding and Improving Therapies for the Muscular Dystrophies
National Institute of Health Niams30 Jul 2021 - 31 Jul 2025
Expired
GRANT
Seven tesla preclinical MRI/S scanner for structural, functional and molecular imaging
National Institute of Health Od18 Jun 2021 - 30 Jun 2023
Expired
GRANT
Understanding and Improving AAV Gene Therapy for DMD
Parent Project Muscular Dystrophy11 Sep 2020 - 31 Jul 2021
Expired
GRANT
Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
National Institute of Health Niams9 Sep 2020 - 31 Aug 2026
Active
GRANT
Task Order #2 - Preclinical work to enable clinical trials with AAV delivery of genes to prevent heart failure
Sarepta Therapeutics7 Jul 2020 - 30 Sep 2021
Expired
GRANT
Myosin 18 and its role in skeletal muscle
National Institute of Health Niams27 Mar 2020 - 31 Mar 2026
Expired
GRANT
Impact and Interplay of Corticosteroid Regimen and Exercise Training on DMD Muscle Function
US Army Med Research Acquisition1 Jul 2019 - 31 Oct 2025
Expired
GRANT
Myo10-Driven Filopodia in Skeletal Muscle
National Institute of Health Niams1 Jul 2019 - 31 May 2025
Expired
GRANT
Structure and Function of Myosin VI
National Institute of Health Nidcd13 Jul 2018 - 30 Jun 2024
Expired
GRANT
Targeting senescent stroma in DMD
Muscular Dystrophy Association18 Dec 2017 - 31 Jul 2021
Expired
GRANT
PPMD conference
Parent Project Muscular Dystrophy19 May 2016 - 31 Jul 2016
Expired
GRANT
New directions in biology and disease of skeletal muscle conference
Bristol Myers Squibb Corporation6 May 2016 - 28 Apr 2017
Expired

GRANTS